In the Media
Israeli Startup DayTwo Offers Personalized Nutrition
“The composition of intestinal bacteria affects the decisions made by our brain. The more I learned about intestinal bacteria, the more it kept me awake at night,” says DayTwo founder and CEO Lihi Segal. Her company is using the breakthrough science of intestinal bacteria for commercial purposes.
The composition of intestinal bacteria is set in most people by age 2, and thereafter changes only slightly. DayTwo’s technology is based on research at the Weizmann Institute led by Prof. Eran Segal and Dr. Eran Elinav, which was first reported in “Globes” in 2013. This research showed that the composition of intestinal bacteria, which is unique for each person, has a differential impact on how that person responds to certain food, and specifically on his blood sugar levels. Eating a banana might greatly increase the blood sugar level for one person with a certain intestinal bacteria composition and eating an apple would not, while another person might have opposite responses to the two fruits.
Read the full article on Weizmann USA here.
Read more remarkable stories like these, understand this new frontier of nutritional science, and learn the tools to discover which of your favorite foods you can include in your own personalized diet plan.
Pre-order your copy of The Personalized Diet today:
As featured in: